CoChat
Sign Up
Cited by 260Liver Disease and TransplantationElectrolyte and hormonal disordersAcute Kidney Injury Research

The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.

Hepatorenal syndrome

Ginès, Pere, Solà, Elsa, Angeli, Paolo, Wong, Florence, Nadim, Mitra K., Kamath, Patrick S.·2018·Nature Reviews Disease Primers
DOI 10.1038/s41572-018-0022-7
Open this paper in CoChat — free account

Abstract

Hepatorenal syndrome (HRS) is a form of kidney function impairment that characteristically occurs in cirrhosis. Recent changes in terminology have led to acute HRS being referred to as acute kidney injury (AKI)-HRS and chronic HRS as chronic kidney disease (CKD)-HRS. AKI-HRS is characterized by a severe impairment of kidney function owing to vasoconstriction of the renal arteries in the absence of substantial abnormalities in kidney histology. Pathogenetic mechanisms involve disturbances in circulatory function due to a marked splanchnic arterial vasodilation, which triggers the activation of vasoconstrictor factors. An intense systemic inflammatory reaction that is characteristic of advanced cirrhosis may also be involved. The main triggering factors of AKI-HRS are bacterial infections, particularly spontaneous bacterial peritonitis. The diagnosis of AKI-HRS is a challenge because of a lack of specific diagnostic tools and mainly involves the differential diagnosis from other forms of AKI, particularly acute tubular necrosis. The prognosis of patients with AKI-HRS is poor, with a median survival of ≤3 months. The ideal treatment for AKI-HRS is liver transplantation in patients without contraindications. Medical therapy consists of vasoconstrictor drugs to counteract splanchnic arterial vasodilation together with volume expansion with albumin. Effective measures to prevent AKI-HRS include early identification and treatment of bacterial infections and the administration of albumin in patients with spontaneous bacterial peritonitis.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41572-018-0022-7

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 155 references

Research works printed but not linked: 1

  1. Ginès, P., Cárdenas, A., Solà, E., Schrier, R. in Schrier’s Diseases of the Kidney (eds Schrier, R. W. et al) 1965–1996 (Lippincott Williams & Wilkins, 2012).

Cited by

Sorted by citations

See all 260

Related

Metadata

Authors
Ginès, P., Solà, E., Angeli, P., Wong, F., Nadim, M. K., & Kamath, P. S.
Affiliations
  • Hospital Clínic de Barcelona (ES)
  • University of Padua (IT)
  • University of Toronto (CA)
  • University of Southern California (US)
  • Mayo Clinic (US)
Corresponding author
Ginès, Pere
ORCID
Venue
Nature Reviews Disease Primers
Publisher
Springer Science and Business Media LLC
Published
2018-09-13
Volume
4
Issue
1
Pages
23-23
ISSN
2056-676X (ISSN-L)
DOI
10.1038/s41572-018-0022-7
OpenAlex
W4211060913
Cited by
260
References
155
Citations by year
2026: 22 · 2025: 31 · 2024: 38 · 2023: 56 · 2022: 32 · 2021: 44 · 2020: 25 · 2019: 9 · 2018: 2
FWCI
2.70
Type
journal article
Language
en
Update notices
correction (2018-10-15)
Open access
closed
Licence
Locations
  • Nature Reviews Disease Primers (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
hepatorenal syndrome, acute kidney injury, chronic kidney disease, liver cirrhosis, renal vasoconstriction, splanchnic vasodilation, systemic inflammation, spontaneous bacterial peritonitis, acute tubular necrosis, liver transplantation, albumin, vasoconstrictor therapy, prevention
MeSH terms
Lipocalin-2, Hepatitis A Virus Cellular Receptor 1, Terlipressin, Bacterial Infections, Creatinine, Hepatorenal Syndrome, Humans, Inflammation, Liver Cirrhosis, Risk Factors, Serum Albumin, Vasoconstrictor Agents, Biomarkers, Interleukin-18, Fatty Acid-Binding Proteins, Acute Kidney Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review